APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biological Indicators

Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.

Selected research

Market Outlook & Growth Opportunities

Global Biological Indicators Market Outlook and Growth Opportunities 2026

21 December 2025191 pages

Choose your research edition.

Industry ResearchBiological Indicators Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Biological Indicators Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biological Indicators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biological Indicators Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Biological Indicators Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.

Global Biological Indicators main players are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share nearly 55%.

This report provides an overview of the global Biological Indicators market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Biological Indicators and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Biological Indicators revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biological Indicators market.

Biological Indicators Segment by Company

3M

Getinge Group

Cantel Medical

Mesa Laboratories

Steris

Fuze Medical

Matachana

Hu-Friedy

Advanced Sterilization

Bag Health Care

Terragene

Andersen

GKE

Biological Indicators Segment by Type

Self-Contained Biological Indicator

Biological Indicator Strip

Biological Indicators Segment by Application

Hospital

Pharma Companies

Others

Biological Indicators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Biological Indicators status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Biological Indicators key companies, revenue, market share, and recent developments.

3. To split the Biological Indicators breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Biological Indicators market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Biological Indicators significant trends, drivers, influence factors in global and regions.

6. To analyze Biological Indicators competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Indicators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biological Indicators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Indicators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biological Indicators industry.

Chapter 3: Detailed analysis of Biological Indicators company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Biological Indicators in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Biological Indicators in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Biological Indicators Industry Trends Table 2. Biological Indicators Industry Drivers Table 3. Biological Indicators Industry Opportunities and Challenges Table 4. Biological Indicators Industry Restraints Table 5. Global Biological Indicators Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Biological Indicators Revenue Share by Company (2021-2026) Table 7. Global Biological Indicators Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Biological Indicators Key Company Manufacturing Base & Headquarters Table 9. Global Biological Indicators Company, Product Type & Application Table 10. Global Biological Indicators Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Biological Indicators by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Self-Contained Biological Indicator Table 15. Significant Companies of Biological Indicator Strip Table 16. Global Biological Indicators Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Biological Indicators Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Biological Indicators Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Biological Indicators Sales Value Share by Type (2021-2026) Table 20. Global Biological Indicators Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Pharma Companies Table 23. Significant Companies of Others Table 24. Global Biological Indicators Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Biological Indicators Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Biological Indicators Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Biological Indicators Sales Value Share by Application (2021-2026) Table 28. Global Biological Indicators Sales Value Share by Application (2027-2032) Table 29. Global Biological Indicators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Biological Indicators Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Biological Indicators Sales Value Share by Region (2021-2026) Table 32. Global Biological Indicators Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Biological Indicators Sales Value Share by Region (2027-2032) Table 34. Global Biological Indicators Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Biological Indicators Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Biological Indicators Sales Value Market Share by Country (2021-2026) Table 37. Global Biological Indicators Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Biological Indicators Sales Value Market Share by Country (2027-2032) Table 39. 3M Company Information Table 40. 3M Business Overview Table 41. 3M Biological Indicators Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. 3M Biological Indicators Product Portfolio Table 43. 3M Recent Development Table 44. Getinge Group Company Information Table 45. Getinge Group Business Overview Table 46. Getinge Group Biological Indicators Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Getinge Group Biological Indicators Product Portfolio Table 48. Getinge Group Recent Development Table 49. Cantel Medical Company Information Table 50. Cantel Medical Business Overview Table 51. Cantel Medical Biological Indicators Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Cantel Medical Biological Indicators Product Portfolio Table 53. Cantel Medical Recent Development Table 54. Mesa Laboratories Company Information Table 55. Mesa Laboratories Business Overview Table 56. Mesa Laboratories Biological Indicators Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Mesa Laboratories Biological Indicators Product Portfolio Table 58. Mesa Laboratories Recent Development Table 59. Steris Company Information Table 60. Steris Business Overview Table 61. Steris Biological Indicators Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Steris Biological Indicators Product Portfolio Table 63. Steris Recent Development Table 64. Fuze Medical Company Information Table 65. Fuze Medical Business Overview Table 66. Fuze Medical Biological Indicators Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Fuze Medical Biological Indicators Product Portfolio Table 68. Fuze Medical Recent Development Table 69. Matachana Company Information Table 70. Matachana Business Overview Table 71. Matachana Biological Indicators Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Matachana Biological Indicators Product Portfolio Table 73. Matachana Recent Development Table 74. Hu-Friedy Company Information Table 75. Hu-Friedy Business Overview Table 76. Hu-Friedy Biological Indicators Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Hu-Friedy Biological Indicators Product Portfolio Table 78. Hu-Friedy Recent Development Table 79. Advanced Sterilization Company Information Table 80. Advanced Sterilization Business Overview Table 81. Advanced Sterilization Biological Indicators Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Advanced Sterilization Biological Indicators Product Portfolio Table 83. Advanced Sterilization Recent Development Table 84. Bag Health Care Company Information Table 85. Bag Health Care Business Overview Table 86. Bag Health Care Biological Indicators Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Bag Health Care Biological Indicators Product Portfolio Table 88. Bag Health Care Recent Development Table 89. Terragene Company Information Table 90. Terragene Business Overview Table 91. Terragene Biological Indicators Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 92. Terragene Biological Indicators Product Portfolio Table 93. Terragene Recent Development Table 94. Andersen Company Information Table 95. Andersen Business Overview Table 96. Andersen Biological Indicators Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 97. Andersen Biological Indicators Product Portfolio Table 98. Andersen Recent Development Table 99. GKE Company Information Table 100. GKE Business Overview Table 101. GKE Biological Indicators Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 102. GKE Biological Indicators Product Portfolio Table 103. GKE Recent Development Table 104. Research Programs/Design for This Report Table 105. Authors List of This Report Table 106. Secondary Sources Table 107. Primary Sources List of Figures Figure 1. Biological Indicators Product Image Figure 2. Global Biological Indicators Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biological Indicators Market Size (2021-2032) & (US$ Million) Figure 4. Global Biological Indicators Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Self-Contained Biological Indicator Image Figure 8. Biological Indicator Strip Image Figure 9. Global Biological Indicators Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Biological Indicators Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Biological Indicators Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Pharma Companies Image Figure 14. Others Image Figure 15. Global Biological Indicators Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Biological Indicators Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Biological Indicators Sales Value Share by Application (2021-2032) Figure 18. Global Biological Indicators Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Biological Indicators Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Biological Indicators Sales Value (2021-2032) & (US$ Million) Figure 21. North America Biological Indicators Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Biological Indicators Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Biological Indicators Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Biological Indicators Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Biological Indicators Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Biological Indicators Sales Value (2021-2032) & (US$ Million) Figure 27. South America Biological Indicators Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Biological Indicators Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Biological Indicators Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Biological Indicators Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Biological Indicators Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Biological Indicators Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Self-Contained Biological Indicator
  • Biological Indicator Strip
Applications
  • Hospital
  • Pharma Companies
  • Others
Companies covered
  • 3M
  • Getinge Group
  • Cantel Medical
  • Mesa Laboratories
  • Steris
  • Fuze Medical
  • Matachana
  • Hu-Friedy
  • Advanced Sterilization
  • Bag Health Care
  • Terragene
  • Andersen
  • GKE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Biological Indicators Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Biological Indicators Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Biological Indicators Market Dynamics
  1. 2.1 Biological Indicators Industry Trends
  2. 2.2 Biological Indicators Industry Drivers
  3. 2.3 Biological Indicators Industry Opportunities and Challenges
  4. 2.4 Biological Indicators Industry Restraints
3 Biological Indicators Market by Company
  1. 3.1 Global Biological Indicators Company Revenue Ranking in 2025
  2. 3.2 Global Biological Indicators Revenue by Company (2021-2026)
  3. 3.3 Global Biological Indicators Company Ranking (2024-2026)
  4. 3.4 Global Biological Indicators Company Manufacturing Base and Headquarters
  5. 3.5 Global Biological Indicators Company Product Type and Application
  6. 3.6 Global Biological Indicators Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Biological Indicators Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Biological Indicators Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Biological Indicators Market by Type
  1. 4.1 Biological Indicators Type Introduction
  2. 4.1.1 Self-Contained Biological Indicator
  3. 4.1.2 Biological Indicator Strip
  4. 4.2 Global Biological Indicators Sales Value by Type
  5. 4.2.1 Global Biological Indicators Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Biological Indicators Sales Value by Type (2021-2032)
  7. 4.2.3 Global Biological Indicators Sales Value Share by Type (2021-2032)
5 Biological Indicators Market by Application
  1. 5.1 Biological Indicators Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharma Companies
  4. 5.1.3 Others
  5. 5.2 Global Biological Indicators Sales Value by Application
  6. 5.2.1 Global Biological Indicators Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Biological Indicators Sales Value by Application (2021-2032)
  8. 5.2.3 Global Biological Indicators Sales Value Share by Application (2021-2032)
6 Biological Indicators Regional Value Analysis
  1. 6.1 Global Biological Indicators Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Biological Indicators Sales Value by Region (2021-2032)
  3. 6.2.1 Global Biological Indicators Sales Value by Region: 2021-2026
  4. 6.2.2 Global Biological Indicators Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Biological Indicators Sales Value (2021-2032)
  7. 6.3.2 North America Biological Indicators Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Biological Indicators Sales Value (2021-2032)
  10. 6.4.2 Europe Biological Indicators Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Biological Indicators Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Biological Indicators Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Biological Indicators Sales Value (2021-2032)
  16. 6.6.2 South America Biological Indicators Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Biological Indicators Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Biological Indicators Sales Value Share by Country, 2025 VS 2032
7 Biological Indicators Country-level Value Analysis
  1. 7.1 Global Biological Indicators Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Biological Indicators Sales Value by Country (2021-2032)
  3. 7.2.1 Global Biological Indicators Sales Value by Country (2021-2026)
  4. 7.2.2 Global Biological Indicators Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Biological Indicators Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Biological Indicators Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Biological Indicators Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Biological Indicators Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Biological Indicators Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Biological Indicators Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Biological Indicators Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Biological Indicators Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Biological Indicators Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Biological Indicators Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Biological Indicators Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Biological Indicators Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Biological Indicators Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Biological Indicators Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Biological Indicators Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Biological Indicators Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Biological Indicators Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Biological Indicators Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Biological Indicators Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Biological Indicators Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Biological Indicators Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Biological Indicators Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Biological Indicators Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Biological Indicators Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Biological Indicators Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Biological Indicators Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Biological Indicators Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Biological Indicators Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Biological Indicators Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Biological Indicators Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Biological Indicators Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Biological Indicators Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Biological Indicators Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Biological Indicators Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Biological Indicators Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Biological Indicators Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Biological Indicators Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Biological Indicators Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Biological Indicators Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Biological Indicators Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Biological Indicators Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Biological Indicators Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Biological Indicators Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Biological Indicators Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Biological Indicators Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Biological Indicators Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Biological Indicators Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Biological Indicators Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Biological Indicators Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Biological Indicators Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Biological Indicators Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Biological Indicators Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Biological Indicators Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Biological Indicators Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Biological Indicators Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Biological Indicators Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Biological Indicators Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Biological Indicators Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Biological Indicators Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Biological Indicators Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Biological Indicators Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Biological Indicators Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Biological Indicators Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Biological Indicators Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Biological Indicators Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Biological Indicators Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Biological Indicators Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Biological Indicators Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Biological Indicators Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Biological Indicators Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Biological Indicators Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Biological Indicators Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Biological Indicators Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Biological Indicators Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Biological Indicators Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Biological Indicators Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Biological Indicators Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Biological Indicators Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Biological Indicators Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Biological Indicators Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Biological Indicators Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Biological Indicators Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Biological Indicators Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Biological Indicators Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 3M
  2. 8.1.1 3M Company Information
  3. 8.1.2 3M Business Overview
  4. 8.1.3 3M Biological Indicators Revenue and Gross Margin (2021-2026)
  5. 8.1.4 3M Biological Indicators Product Portfolio
  6. 8.1.5 3M Recent Developments
  7. 8.2 Getinge Group
  8. 8.2.1 Getinge Group Company Information
  9. 8.2.2 Getinge Group Business Overview
  10. 8.2.3 Getinge Group Biological Indicators Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Getinge Group Biological Indicators Product Portfolio
  12. 8.2.5 Getinge Group Recent Developments
  13. 8.3 Cantel Medical
  14. 8.3.1 Cantel Medical Company Information
  15. 8.3.2 Cantel Medical Business Overview
  16. 8.3.3 Cantel Medical Biological Indicators Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Cantel Medical Biological Indicators Product Portfolio
  18. 8.3.5 Cantel Medical Recent Developments
  19. 8.4 Mesa Laboratories
  20. 8.4.1 Mesa Laboratories Company Information
  21. 8.4.2 Mesa Laboratories Business Overview
  22. 8.4.3 Mesa Laboratories Biological Indicators Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mesa Laboratories Biological Indicators Product Portfolio
  24. 8.4.5 Mesa Laboratories Recent Developments
  25. 8.5 Steris
  26. 8.5.1 Steris Company Information
  27. 8.5.2 Steris Business Overview
  28. 8.5.3 Steris Biological Indicators Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Steris Biological Indicators Product Portfolio
  30. 8.5.5 Steris Recent Developments
  31. 8.6 Fuze Medical
  32. 8.6.1 Fuze Medical Company Information
  33. 8.6.2 Fuze Medical Business Overview
  34. 8.6.3 Fuze Medical Biological Indicators Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Fuze Medical Biological Indicators Product Portfolio
  36. 8.6.5 Fuze Medical Recent Developments
  37. 8.7 Matachana
  38. 8.7.1 Matachana Company Information
  39. 8.7.2 Matachana Business Overview
  40. 8.7.3 Matachana Biological Indicators Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Matachana Biological Indicators Product Portfolio
  42. 8.7.5 Matachana Recent Developments
  43. 8.8 Hu-Friedy
  44. 8.8.1 Hu-Friedy Company Information
  45. 8.8.2 Hu-Friedy Business Overview
  46. 8.8.3 Hu-Friedy Biological Indicators Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Hu-Friedy Biological Indicators Product Portfolio
  48. 8.8.5 Hu-Friedy Recent Developments
  49. 8.9 Advanced Sterilization
  50. 8.9.1 Advanced Sterilization Company Information
  51. 8.9.2 Advanced Sterilization Business Overview
  52. 8.9.3 Advanced Sterilization Biological Indicators Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Advanced Sterilization Biological Indicators Product Portfolio
  54. 8.9.5 Advanced Sterilization Recent Developments
  55. 8.10 Bag Health Care
  56. 8.10.1 Bag Health Care Company Information
  57. 8.10.2 Bag Health Care Business Overview
  58. 8.10.3 Bag Health Care Biological Indicators Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bag Health Care Biological Indicators Product Portfolio
  60. 8.10.5 Bag Health Care Recent Developments
  61. 8.11 Terragene
  62. 8.11.1 Terragene Company Information
  63. 8.11.2 Terragene Business Overview
  64. 8.11.3 Terragene Biological Indicators Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Terragene Biological Indicators Product Portfolio
  66. 8.11.5 Terragene Recent Developments
  67. 8.12 Andersen
  68. 8.12.1 Andersen Company Information
  69. 8.12.2 Andersen Business Overview
  70. 8.12.3 Andersen Biological Indicators Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Andersen Biological Indicators Product Portfolio
  72. 8.12.5 Andersen Recent Developments
  73. 8.13 GKE
  74. 8.13.1 GKE Company Information
  75. 8.13.2 GKE Business Overview
  76. 8.13.3 GKE Biological Indicators Revenue and Gross Margin (2021-2026)
  77. 8.13.4 GKE Biological Indicators Product Portfolio
  78. 8.13.5 GKE Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst